EUVIMEDEUVIMED entdecken
Crossref

Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ T helper 2 cells which may contribute to pruritus in lesional skin

Wilson Jr F Aala, Ping-Chen Hou, Yi-Kai Hong, Yu-Chen Lin, Yu-Rong Lee, Wei-Ting Tu, Marieta Papanikolaou, Natashia Benzian-Olsson, Alexandros Onoufriadis, Hans I Chen Harn, Daw-Yang Hwang, Siao Muk Cheng und 4 weitere

British Journal of Dermatology · 2024

DOI: 10.1093/bjd/ljae110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Wilson Jr F Aala und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Epidermolysis Bullosa Dystrophica, Pruritus, Th2 Cells, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Ministry of Science and Technology Council, National Cheng Kung University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dominant dystrophic epidermolysis bullosa (DDEB) is characterized by trauma-induced blisters and, in some individuals, intense pruritus. Precisely what causes itch in DDEB and optimal ways to reduce it have not been fully determined.

Objectives

To characterize DDEB skin transcriptomes to identify therapeutic targets to reduce pruritus in patients.

Methods

Using bulk RNA sequencing, we evaluated affected and unaffected skin biopsy samples from six patients with DDEB (all with the very itchy pruriginosa subtype) and four healthy individuals. Single-cell transcriptomes of affected (n = 2) and unaffected (n = 1) DDEB skin and healthy skin (n = 2) were obtained. Dupilumab treatment was provided for three patients.

Results

The skin bulk transcriptome showed significant enrichment of T helper (Th)1/2 and Th17 pathways in affected DDEB skin compared with nonlesional DDEB skin and healthy skin. Single-cell transcriptomics showed an association of glycolytically active GATA3+ Th2 cells in affected DDEB skin. Treatment with dupilumab in three people with DDEB led to significantly reduced visual analogue scale (VAS) itch scores after 12 weeks (mean VAS 3.83) compared with pretreatment (mean VAS 7.83). Bulk RNAseq and quantitative polymerase chain reaction showed that healthy skin and dupilumab-treated epidermolysis bullosa (EB) pruriginosa skin have similar transcriptomic profiles and reduced Th1/Th2 and Th17 pathway enrichment.

Conclusions

Single-cell RNAseq helps define an enhanced DDEB-associated Th2 profile and rationalizes drug repurposing of anti-Th2 drugs in treating DDEB pruritus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epidermolysis Bullosa DystrophicaPruritusTh2 CellsAntibodies, Monoclonal, HumanizedGATA3 Transcription FactorSkinHumansMaleFemaleAdultTranscriptomeCase-Control StudiesMiddle AgedSingle-Cell Analysis

Substanzen

Antibodies, Monoclonal, HumanizedGATA3 Transcription FactordupilumabGATA3 protein, human

Autor:innen und Institutionen

  • Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • International Center for Wound Repair and Regeneration, National Cheng Kung University, Tainan, Taiwan.
  • School of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, UK.
  • Laboratory of Medical Biology and Genetics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

ORCID-Profile: Kurt Lu, John A McGrath, Chao-Kai Hsu

Förderung

  • Ministry of Science and Technology Council
  • National Cheng Kung University Hospital

Zitieren

APA

Aala, W. J. F., Hou, P. C., Hong, Y. K., Lin, Y. C., Lee, Y. R., Tu, W. T., Papanikolaou, M., Benzian-Olsson, N., Onoufriadis, A., I Chen Harn, H., Hwang, D. Y., Cheng, S. M., Lu, K., Chen, P. C., McGrath, J. A., & Hsu, C. K. (2024). Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ T helper 2 cells which may contribute to pruritus in lesional skin. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae110

Vancouver

Aala WJF, Hou PC, Hong YK, Lin YC, Lee YR, Tu WT, et al. Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ T helper 2 cells which may contribute to pruritus in lesional skin. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae110

BibTeX
@article{Aala2024,
  author = {Aala, Wilson Jr F and Hou, Ping-Chen and Hong, Yi-Kai and Lin, Yu-Chen and Lee, Yu-Rong and Tu, Wei-Ting and Papanikolaou, Marieta and Benzian-Olsson, Natashia and Onoufriadis, Alexandros and I Chen Harn, Hans and Hwang, Daw-Yang and Cheng, Siao Muk and Lu, Kurt and Chen, Peng-Chieh and McGrath, John A and Hsu, Chao-Kai},
  title = {Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ T helper 2 cells which may contribute to pruritus in lesional skin},
  journal = {British Journal of Dermatology},
  year = {2024},
  doi = {10.1093/bjd/ljae110}
}
Kostenlos starten →